Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Physical activity increased, but sedentary behavior also rose, especially in men.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

COVID-19 vaccines can cause minor skin reactions, including those related to Bullous Pemphigoid, but these usually resolve on their own.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

COVID-19 and its vaccine can cause skin issues, but most are minor and resolve on their own.

Pharmacist-led care significantly improved post-COVID symptoms.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Post-COVID-19 patients are at risk for hair loss.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Severe COVID-19 increases the risk of hair loss.

Anemia increases the risk of hair loss in post-COVID-19 survivors.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.